The U.S. long term care software market size was estimated at around USD 1.41 billion in 2023 and it is projected to hit around USD 4.2 billion by 2033, growing at a CAGR of 11.52% from 2024 to 2033. Key Pointers By Mode of Delivery, the cloud-...
The global cell penetrating peptide market size was estimated at around USD 1.49 billion in 2023 and it is projected to hit around USD 3.9 billion by 2033, growing at a CAGR of 10.09% from 2024 to 2033. Key Pointers North America dominated the ...
The global over-the-counter (OTC) analgesics market was valued at USD 29.54 billion in 2023 and it is predicted to surpass around USD 42.56 billion by 2033 with a CAGR of 3.72% from 2024 to 2033. Key Pointers North America dominated the market ...
The global single cell genome sequencing market size was estimated at around USD 2.68 billion in 2023 and it is projected to hit around USD 11.97 billion by 2033, growing at a CAGR of 16.14% from 2024 to 2033. Key Pointers North America d...
The U.S. virtual visits market was estimated at USD 15.89 billion in 2023 and it is expected to surpass around USD 218.07 billion by 2033, poised to grow at a CAGR of 29.94% from 2024 to 2033. Key Pointers In terms of gender, the female segment...
The Europe digital health market was surpassed at USD 66.23 billion in 2023 and is expected to hit around USD 497.44 billion by 2033, growing at a CAGR of 22.34% from 2024 to 2033. Key Pointers By Technology, the tele-healthcare segment held th...
The U.S. antisense and RNAi therapeutics market size was estimated at around USD 2.78 billion in 2023 and it is projected to hit around USD 16.01 billion by 2033, growing at a CAGR of 19.13% from 2024 to 2033. Key Pointers By Route of Administr...
The U.S. Cell Therapy market was estimated at USD 2.68 billion in 2023 and it is expected to surpass around USD 18.36 billion by 2033, poised to grow at a CAGR of 21.22% from 2024 to 2033. The U.S. cell therapy market has witnessed significant growth...
The U.S. genotyping market was estimated at USD 6.46 billion in 2023 and it is expected to surpass around USD 23.39 billion by 2033, poised to grow at a CAGR of 13.73% from 2024 to 2033. Key Pointers By Product, the reagents and kits segment he...
The North America bloodstream infection testing market size was estimated at around USD 318.19 million in 2023 and it is projected to hit around USD 454.07 million by 2033, growing at a CAGR of 3.62% from 2024 to 2033. Key Pointers By Product, ...